17.01.2015 Views

LibraryPirate

LibraryPirate

LibraryPirate

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

286 CHAPTER 7 HYPOTHESIS TESTING<br />

Treatment Mean Standard Error of Mean<br />

Etanercept 5.56 0.84<br />

Etanercept plus methotrexate 4.40 0.57<br />

21. Miyazaki et al. (A-36) examined the recurrence-free rates of stripping with varicectomy and stripping<br />

with sclerotherapy for the treatment of primary varicose veins. The varicectomy group consisted<br />

of 122 limbs for which the procedure was done, and the sclerotherapy group consisted of 98<br />

limbs for which that procedure was done. After 3 years, 115 limbs of the varicectomy group and 87<br />

limbs of the sclerotherapy group were recurrence-free. Is this sufficient evidence for us to conclude<br />

there is no difference, in general, in the recurrence-free rate between the two procedures for treating<br />

varicose veins Let a = .05.<br />

22. Recall the study, reported in Exercise 7.8.1, in which Dora et al. (A-37) investigated spinal<br />

canal dimensions in 30 subjects symptomatic with disc herniation selected for a discectomy<br />

and 45 asymptomatic individuals (control group). One of the areas of interest was determining<br />

if there is a difference between the two groups in the spinal canal cross-sectional area (cm 2 )<br />

between vertebrae L5/S1. The data in the following table are simulated to be consistent with<br />

the results reported in the paper. Do these simulated data provide evidence for us to conclude<br />

that a difference in the spinal canal cross-sectional area exists between a population of subjects<br />

with disc herniations and a population of those who do not have disc herniations Let<br />

a = .05.<br />

Herniated Disc Group<br />

Control Group<br />

2.62 2.57 1.98 3.21 3.59 3.72 4.30 2.87 3.87 2.73 5.28<br />

1.60 1.80 3.91 2.56 1.53 1.33 2.36 3.67 1.64 3.54 3.63<br />

2.39 2.67 3.53 2.26 2.82 4.26 3.08 3.32 4.00 2.76 3.58<br />

2.05 1.19 3.01 2.39 3.61 3.11 3.94 4.39 3.73 2.22 2.73<br />

2.09 3.79 2.45 2.55 2.10 5.02 3.62 3.02 3.15 3.57 2.37<br />

2.28 2.33 2.81 3.70 2.61 5.42 3.35 2.62 3.72 4.37 5.28<br />

4.97 2.58 2.25 3.12 3.43<br />

3.95 2.98 4.11 3.08 2.22<br />

Source: Simulated data.<br />

23. Iannelo et al. (A-38) investigated differences between triglyceride levels in healthy obese (control)<br />

subjects and obese subjects with chronic active B or C hepatitis. Triglyceride levels of<br />

208 obese controls had a mean value of 1.81 with a standard error of the mean of .07 mmol/L.<br />

The 19 obese hepatitis subjects had a mean of .71 with a standard error of the mean of .05. Is<br />

this sufficient evidence for us to conclude that, in general, a difference exists in average triglyceride<br />

levels between obese healthy subjects and obese subjects with hepatitis B or C Let<br />

a = .01.<br />

24. Kindergarten students were the participants in a study conducted by Susan Bazyk et al. (A-39).<br />

The researchers studied the fine motor skills of 37 children receiving occupational therapy. They<br />

used an index of fine motor skills that measured hand use, eye–hand coordination, and manual

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!